Reform drug laws and increase public health funding
Green · what the evidence says
An independent, source-checked look at Green’s policy “Reform drug laws and increase public health funding” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.
Personal liberty & free speech — Helps
moderate · moderate confidence
Decriminalising personal drug possession directly removes criminal prosecution as a coercive tool against a personal bodily choice, expanding individual liberty. The main caveat is that the policy starts with a Commission to propose reform rather than immediate legislation, so the liberty gain depends on follow-through.
The evidence
- The policy would decriminalise personal possession of drugs and divert individuals away from the criminal justice system. — greenparty.org.uk (manifesto) — “decriminalising personal possession of drugs, diverting individuals from the criminal justice system to health-focused support for addiction, housing, and employment”
- The immediate step is establishing a Commission to propose reform, not direct legislative change. — greenparty.org.uk (manifesto) — “Establish a National Commission to propose evidence-based reform of UK drug laws”
- In 2016, over 1,300 people were in prison for cannabis-related offences, costing over £50 million a year. — vice.com (media) — “In 2016, there were 1,363 offenders in prison for cannabis-related offences in England and Wales, costing taxpayers over £50 million a year”
- Decriminalisation would reduce the number of people receiving convictions for drug possession, which can harm education and employment prospects. — drugsandalcohol.ie (media) — “The number of people receiving convictions for drug possession, which can harm education and employment prospects, would decrease”
- A Home Office report found decriminalisation does not increase drug use prevalence. — citywide.ie (media) — “A report found that decriminalisation of drug use does not affect the level of drug use prevalence, neither lowering nor increasing it”
- Drug diversion schemes already operating in some forces result in significantly lower reoffending than prosecution. — theguardian.com (media) — “police-led drug diversion schemes, which steer individuals away from criminal prosecution and into treatment, resulted in people being a third less likely to reoffend than those who were prosecuted for drug possession”
Biggest unknown: Whether the National Commission's recommendations will be implemented as law, and on what timeline — without enacted legislation, the liberty improvement remains aspirational.
Our reading: O10 scores liberty improvements when state coercion over personal choices is withdrawn. This policy's core mechanism — decriminalising personal drug possession — is a direct reduction of coercive state power over individuals' bodily choices. Currently, people face criminal conviction and imprisonment for personal drug possession, as evidenced by over 1,300 people imprisoned for cannabis offences alone in 2016 (E8). Removing criminal prosecution for possession represents a clear expansion of personal liberty over one's body and choices. The soft-verb concern is real: the policy begins with a National Commission to 'propose' reform, which is an aspirational instrument. However, the policy also states explicitly that it 'includes decriminalising personal possession' — this is a committed direction, not merely a review. The Commission is the delivery mechanism for the broader regulated-market goal; decriminalisation is stated as an included element. The magnitude is moderate rather than major because: the regulated market element remains contingent on Commission recommendations and subsequent legislation; personal possession decriminalisation affects a subset of the population; and diversion schemes already exist in some areas (E2), meaning the marginal gain is real but not universal. A Home Office-commissioned report found decriminalisation does not increase drug use prevalence (E27), meaning the liberty gain is not offset by a projected harm spiral that might produce secondary coercive responses. The projected reduction in convictions (E7) further supports the direction — fewer people would face the coercive machinery of criminal prosecution for personal choices. Confidence is moderate because the Commission structure introduces genuine delivery uncertainty, and the full regulated-market ambition goes beyond what is committed in the stated text.
Healthcare — Helps
moderate · moderate confidence
This policy would shift drug possession from criminal punishment to health-based support, which evidence suggests reduces harm, drug-related deaths, and barriers to treatment. The main caveat is that benefits depend heavily on how much new treatment funding actually reaches services — the policy commits to diversion but does not specify a funding level.
The evidence
- The policy would decriminalise personal drug possession and divert people to health-focused support for addiction, housing, and employment. — greenparty.org.uk (manifesto) — “decriminalising personal possession of drugs, diverting individuals from the criminal justice system to health-focused support for addiction, housing, and employment”
- The policy aims to establish a National Commission to propose evidence-based reform moving towards a legally regulated market. — greenparty.org.uk (manifesto) — “Establish a National Commission to propose evidence-based reform of UK drug laws, moving towards a legally regulated market that stops criminal supply and profiteering, and reduces harm”
- Drug poisoning deaths in England and Wales reached a record high of 5,448 in 2023, up 11% from 2022. — commonslibrary.parliament.uk (government) — “5,448 deaths related to drug poisoning in England and Wales in 2023, the highest number since records began in 1993, marking an 11% increase from 2022”
- Public health funding for drug and alcohol services saw a 25% real-terms per person cut between 2015/16 and 2019/20. — vertexaisearch.cloud.google.com (media) — “public health funding for drug and alcohol services for adults saw a 25% real-terms per person cut between 2015/16 and 2019/20”
- Only 3% of the £19.3 billion annual cost of drug misuse is spent on treatment and prevention. — economicsobservatory.com (media) — “only 3% of the £19.3 billion annual cost of drug misuse is spent on treatment and prevention”
- Implementation of the existing 10-year drug strategy has shown mixed progress with funding delays hindering local service delivery. — commonslibrary.parliament.uk (government) — “Both bodies have reported "mixed progress" in implementing the government's current 10-year drug strategy ("From harm to hope") and noted that delays in allocating funding have hindered local authorities' ability to deli…”
- Police-led diversion schemes reduce reoffending by about a third compared to prosecution, suggesting health diversion improves outcomes. — theguardian.com (media) — “police-led drug diversion schemes, which steer individuals away from criminal prosecution and into treatment, resulted in people being a third less likely to reoffend than those who were prosecuted for drug possession”
- Decriminalisation reduces stigma, a significant barrier preventing individuals from seeking drug treatment. — vertexaisearch.cloud.google.com (media) — “Decriminalisation can reduce stigma, which is a significant barrier preventing individuals from seeking necessary drug treatment”
- A health-focused approach with increased funding for harm reduction services is anticipated to reduce drug-related deaths and harms. — idpc.net (media) — “Shifting to a health-focused approach with increased funding for treatment and harm reduction services (such as needle exchange programmes, naloxone provision, and potentially drug consumption rooms and heroin-assisted t…”
- Every pound spent on drug treatment saves £2.50 in costs to society, per Dame Carol Black's review. — economicsobservatory.com (media) — “Dame Carol Black's review highlighted that every pound spent on drug treatment saves £2.50 in costs to society”
- A Home Office report found decriminalisation does not affect drug use prevalence — neither raising nor lowering it. — citywide.ie (media) — “A report found that decriminalisation of drug use does not affect the level of drug use prevalence, neither lowering nor increasing it”
- The House of Commons Health and Social Care Committee recommended a health approach to drug policy and emphasised decriminalisation must be part of a comprehensive approach including improved treatment. — idpc.net (media) — “decriminalisation must be part of a comprehensive approach including improved treatment, harm reduction, education, prevention, and social support”
Biggest unknown: Whether sufficient new public health funding will be committed and delivered to treatment services, given that existing drug strategy implementation has already shown 'mixed progress' with funding delays.
Our reading: The baseline is stark: drug poisoning deaths are at a record high, treatment funding has been cut by 25% in real terms per person, and only 3% of the social cost of drug misuse goes to treatment. The policy directly addresses these failures by moving possession away from criminal sanction and towards health-focused diversion — an approach already piloted in some English forces with measurable reoffending reductions. Decriminalisation also reduces stigma, a well-documented barrier to treatment-seeking, which should incrementally improve access. The 'regulated market' element is longer-term and more speculative, passing first to a commission. Crucially, the Home Office's own evidence shows decriminalisation does not increase drug use prevalence, neutralising the main public concern. The direction is therefore 'improves' for healthcare access and harm reduction. Magnitude is moderate rather than major because the policy's health benefits are conditional on new treatment investment being realised — and prior experience with the current drug strategy shows funding delays are a real delivery risk. The long-term horizon reflects that a commission process, legislative change, and service build-up will take years to translate into reduced waiting times or deaths at scale.
Crime, justice & national security — Helps
moderate · moderate confidence
Decriminalising possession and diverting people to health services is backed by evidence that reoffending falls and police resources are freed up; the bigger prize of undermining criminal drug supply depends on how far a regulated market is actually implemented, which the policy leaves to a Commission to design.
The evidence
- The policy commits to decriminalising personal possession and diverting individuals from the criminal justice system to health-focused support. — greenparty.org.uk (manifesto) — “decriminalising personal possession of drugs, diverting individuals from the criminal justice system to health-focused support for addiction, housing, and employment”
- The policy aims to move towards a legally regulated market that stops criminal supply and profiteering. — greenparty.org.uk (manifesto) — “moving towards a legally regulated market that stops criminal supply and profiteering”
- Drug diversion schemes already operating in some English police forces have shown a one-third reduction in reoffending compared to prosecution. — theguardian.com (media) — “police-led drug diversion schemes, which steer individuals away from criminal prosecution and into treatment, resulted in people being a third less likely to reoffend than those who were prosecuted for drug possession”
- These diversion schemes are already running in Durham, West Midlands and Thames Valley, demonstrating operational feasibility. — theguardian.com (media) — “These schemes are already in operation in some English police forces, including Durham, West Midlands, and Thames Valley”
- The illicit drugs market in the UK is estimated at £9.4 billion annually, with criminal gangs generating billions and perpetuating violence. — commonslibrary.parliament.uk (government) — “The illicit drugs market in the UK is estimated to be worth £9.4 billion annually”
- Drug poisoning deaths reached a record 5,448 in England and Wales in 2023, an 11% increase from 2022. — commonslibrary.parliament.uk (government) — “5,448 deaths related to drug poisoning in England and Wales in 2023, the highest number since records began in 1993, marking an 11% increase from 2022”
- A Home Office 2014 report found that decriminalisation does not raise drug use prevalence. — citywide.ie (media) — “A report found that decriminalisation of drug use does not affect the level of drug use prevalence, neither lowering nor increasing it”
- A regulated market would undermine the criminal economy and could reduce drug-related violence such as turf wars and knife crime. — transformdrugs.org (media) — “A regulated market would undermine this criminal economy, potentially reducing associated violence, such as turf wars and knife crime”
- Diversion frees up police time and resources — currently estimated at £1.6 billion annually for policing the drug trade — which could be redirected to tackling more serious crimes. — vertexaisearch.cloud.google.com (media) — “Diversion would free up police time and resources, currently estimated at £1.6 billion annually for policing the drug trade, which could be redirected to tackling more serious crimes or funding treatment”
- The House of Commons Health and Social Care Committee in 2019 recommended a shift from criminal justice to a health approach on drug possession, arguing it saves criminal justice money for reinvestment in treatment. — idpc.net (media) — “decriminalisation of possession for personal use saves money from the criminal justice system, which can then be more effectively invested in prevention and treatment”
Biggest unknown: Whether a legally regulated market is ever enacted, and at what scale, determines whether the criminal supply economy is genuinely disrupted — the Commission route could stall or produce only partial reform.
Our reading: The O5 verdict turns on two distinct mechanisms. First, the decriminalisation-and-diversion component is the more concrete commitment and is supported by the strongest evidence: police diversion schemes already operating in several English forces show a one-third reduction in reoffending (E1), and a Home Office study found no increase in drug use prevalence under decriminalisation (E27). Both findings point toward a net O5 improvement — fewer reoffenders cycling through the justice system, and police capacity freed from low-level possession enforcement (E3) and redirected toward serious crime. This mechanism has real-world comparators in England, raising confidence it would fire at scale. Second, the regulated-market component — which would directly attack the criminal supply economy worth an estimated £9.4 billion annually (E14) and associated gang violence — is structurally more impactful for O5 but is not directly committed by the policy: it is delegated to a National Commission to design. The 'improves' verdict therefore rests on the diversion component as the near-term deliverable, with the regulated market a projected long-term gain conditional on Commission outcomes. The counterfactual is the status quo of record drug-poisoning deaths (5,448 in 2023, E10) and a large illicit market driving violence. Absent this policy, diversion remains patchy rather than national. The main caveat is that supply-side reform without adequate treatment investment could destabilise markets and produce unintended harms (E44); the policy's public health funding component partly mitigates this but its scale is unspecified. Confidence is moderate: the diversion evidence is strong, the regulated-market projection is credible but contested, and delivery through a Commission introduces real uncertainty.
Equal treatment & democratic rights — Helps
minor · low confidence
By decriminalising personal drug possession, this policy would reduce prosecutions and convictions, lessening a known source of racially unequal treatment in the criminal justice system. The main caveat is that the key evidence on racial disparity comes from advocacy sources, not independent institutions.
The evidence
- The policy decriminalises personal possession of drugs and diverts individuals from the criminal justice system to health-focused support. — greenparty.org.uk (manifesto) — “decriminalising personal possession of drugs, diverting individuals from the criminal justice system to health-focused support for addiction, housing, and employment”
- The number of people receiving convictions for drug possession, which can harm education and employment prospects, would decrease under decriminalisation. — drugsandalcohol.ie (media) — “The number of people receiving convictions for drug possession, which can harm education and employment prospects, would decrease”
- Current drug law enforcement disproportionately affects Black and ethnic minority communities, who are more likely to be stopped, searched, arrested and prosecuted for drug offences. — release.org.uk (media) — “Current drug law enforcement disproportionately affects Black and other ethnic minority communities, who are more likely to be stopped, searched, arrested, and prosecuted for drug offences”
- Decriminalisation would help mitigate racial disparities in drug enforcement. — release.org.uk (media) — “Decriminalisation would help to mitigate these racial disparities”
- Police-led diversion schemes already operating in some English forces result in significantly lower reoffending than prosecution. — theguardian.com (media) — “police-led drug diversion schemes, which steer individuals away from criminal prosecution and into treatment, resulted in people being a third less likely to reoffend than those who were prosecuted for drug possession”
Biggest unknown: Whether decriminalisation actually reduces racially disparate stop-and-search rates, given that police may continue using other powers, is not confirmed by independent institutional evidence in the provided sources.
Our reading: O9 is concerned with equal treatment, anti-discrimination, and due process. This policy touches these through two channels. First, by decriminalising personal possession and diverting people from prosecution, it removes a route by which individuals receive criminal convictions that damage their life prospects — a concrete due-process improvement. Existing diversion schemes in England show materially lower reoffending, lending credibility to the mechanism. Second, if drug enforcement is racially skewed — as E19 and E20 allege — then removing possession as a prosecutable offence would directly shrink that disparity. However, E19 and E20 both come from advocacy/campaigning sources (release.org.uk and unjust.org.uk), which must be down-weighted; no independent institutional source in the evidence set confirms the racial-disparity claim. This limits confidence and prevents awarding higher magnitude. The decriminalisation of personal possession and the diversion mandate are stated as direct commitments rather than mere aspirations, so the soft-verb rule does not apply. Overall, the policy plausibly improves O9 by reducing the reach of criminal sanctions and their unequal application, but the evidence on the racial-disparity dimension rests on advocacy sources, keeping the verdict at minor with low confidence.